{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:38:00Z","timestamp":1778873880048,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":21,"publisher":"Springer New York","isbn-type":[{"value":"9781493920129","type":"print"},{"value":"9781493920136","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-1-4939-2013-6_4","type":"book-chapter","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T16:06:01Z","timestamp":1414425961000},"page":"53-66","source":"Crossref","is-referenced-by-count":8,"title":["HPV Binding Assay to Laminin-332\/Integrin \u03b16\u03b24 on Human Keratinocytes"],"prefix":"10.1007","author":[{"given":"Sarah A.","family":"Brendle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil D.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,12]]},"reference":[{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.vaccine.2006.05.111","volume":"24","author":"DM Parkin","year":"2006","unstructured":"Parkin DM, Bray F (2006) The burden of HPV-related cancers. Vaccine 24:11\u201325","journal-title":"Vaccine"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/jnci\/djq562","volume":"103","author":"M Schiffman","year":"2011","unstructured":"Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE (2011) Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103:368\u2013383","journal-title":"J Natl Cancer Inst"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3322\/caac.21167","volume":"63","author":"DP Zandberg","year":"2013","unstructured":"Zandberg DP, Bhargava R, Badin S, Cullen KJ (2013) The role of human papillomavirus in nongenital cancers. CA Cancer J Clin 63: 57\u201381","journal-title":"CA Cancer J Clin"},{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"8940","DOI":"10.1128\/JVI.00724-06","volume":"80","author":"TD Culp","year":"2006","unstructured":"Culp TD, Budgeon LR, Marinkovich MP, Meneguzzi G, Christensen ND (2006) Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol 80:8940\u20138950","journal-title":"J Virol"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1073\/pnas.0508815103","volume":"103","author":"RM Richards","year":"2006","unstructured":"Richards RM, Lowy DR, Schiller JT, Day PM (2006) Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci U S A 103:1522\u20131527","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"7206","DOI":"10.1111\/j.1742-4658.2009.07400.x","volume":"276","author":"M Sapp","year":"2009","unstructured":"Sapp M, Bienkowska-Haba M (2009) Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus. FEBS J 276:7206\u20137216","journal-title":"FEBS J"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.ygyno.2010.04.004","volume":"118","author":"JT Schiller","year":"2010","unstructured":"Schiller JT, Day PM, Kines RC (2010) Current understanding of the mechanism of HPV infection. Gynecol Oncol 118:S12\u2013S17","journal-title":"Gynecol Oncol"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.virol.2005.11.025","volume":"347","author":"TD Culp","year":"2006","unstructured":"Culp TD, Budgeon LR, Christensen ND (2006) Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor. Virology 347:147\u2013159","journal-title":"Virology"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1099\/vir.0.012732-0","volume":"91","author":"TR Broutian","year":"2010","unstructured":"Broutian TR, Brendle SA, Christensen ND (2010) Differential binding patterns to host cells associated with particles of several human alphapapillomavirus types. J Gen Virol 91: 531\u2013540","journal-title":"J Gen Virol"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb.106.3.761","volume":"106","author":"P Boukamp","year":"1988","unstructured":"Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761\u2013771","journal-title":"J Cell Biol"},{"key":"4_CR11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/JVI.61.2.590-593.1987","volume":"61","author":"JW Kreider","year":"1987","unstructured":"Kreider JW, Howett MK, Leuredupree AE, Zaino RJ, Weber JA (1987) Laboratory production in vivo of infectious human papillomavirus type-11. J Virol 61:590\u2013593","journal-title":"J Virol"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1006\/viro.1994.1649","volume":"205","author":"ND Christensen","year":"1994","unstructured":"Christensen ND, Kirnbauer R, Schiller JT et al (1994) Human papillomavirus type-6 and type-11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology 205:329\u2013335","journal-title":"Virology"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.1323879","volume":"257","author":"C Meyers","year":"1992","unstructured":"Meyers C, Frattini MG, Hudson JB, Laimins LA (1992) Biosynthesis of human papillomavirus from a continuous cell-line upon epithelial differentiation. Science 257:971\u2013973","journal-title":"Science"},{"issue":"Pt 7","key":"4_CR14","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1099\/vir.0.017228-0","volume":"91","author":"SA Brendle","year":"2010","unstructured":"Brendle SA, Culp TD, Broutian TR, Christensen ND (2010) Binding and neutralization characteristics of a panel of monoclonal antibodies to Human Papillomavirus 58. J Gen Virol 91(Pt 7):1834\u20131839","journal-title":"J Gen Virol"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1006\/viro.1996.0466","volume":"223","author":"ND Christensen","year":"1996","unstructured":"Christensen ND, Dillner J, Eklund C et al (1996) Surface conformational and linear epitopes on HPV-16 and HPV-18L1 virus-like particles as defined by monoclonal antibodies. Virology 223:174\u2013184","journal-title":"Virology"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1006\/viro.1995.1059","volume":"207","author":"ND Christensen","year":"1995","unstructured":"Christensen ND, Cladel NM, Reed CA (1995) Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies. Virology 207:136\u2013142","journal-title":"Virology"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1006\/viro.1996.0554","volume":"224","author":"ND Christensen","year":"1996","unstructured":"Christensen ND, Reed CA, Cladel NM, Hall K, Leiserowitz GS (1996) Monoclonal antibodies to HPV-6L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6. Virology 224:477\u2013486","journal-title":"Virology"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"12393","DOI":"10.1128\/JVI.01583-06","volume":"80","author":"AF Mejia","year":"2006","unstructured":"Mejia AF, Culp TD, Cladel NM et al (2006) Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV\/cottontail rabbit papillomavirus chimeric papillomavirus particles. J Virol 80: 12393\u201312397","journal-title":"J Virol"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1128\/JVI.78.2.751-757.2004","volume":"78","author":"CB Buck","year":"2004","unstructured":"Buck CB, Pastrana DV, Lowy DR, Schiller JT (2004) Efficient intracellular assembly of papillomaviral vectors. J Virol 78:751\u2013757","journal-title":"J Virol"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1128\/JVI.79.5.2839-2846.2005","volume":"79","author":"CB Buck","year":"2005","unstructured":"Buck CB, Thompson CD, Pang YYS, Lowy DR, Schiller JT (2005) Maturation of papillomavirus capsids. J Virol 79:2839\u20132846","journal-title":"J Virol"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1006\/viro.2001.1220","volume":"291","author":"ND Christensen","year":"2001","unstructured":"Christensen ND, Cladel NM, Reed CA et al (2001) Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types. Virology 291:324\u2013334","journal-title":"Virology"}],"container-title":["Methods in Molecular Biology","Cervical Cancer"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-2013-6_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T05:00:20Z","timestamp":1598418020000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-2013-6_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,12]]},"ISBN":["9781493920129","9781493920136"],"references-count":21,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-2013-6_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,12]]}}}